• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏血管平滑肌脂肪瘤的超声造影特征:与甲胎蛋白阴性及非病毒性肝细胞癌的比较

Contrast-enhanced ultrasound features of hepatic angiomyolipoma: comparison with AFP-negative and non-viral hepatocellular carcinoma.

作者信息

Zhang Yafang, Guo Zhi-Xing, Liao Ying, Yu Yiwen, Guo Ruohan, Han Xu, Lan Lilong, Zhou Jianhua

机构信息

Department of Ultrasound, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Ultrasound Int Open. 2024 Jun 14;10:a23186654. doi: 10.1055/a-2318-6654. eCollection 2024.

DOI:10.1055/a-2318-6654
PMID:39411752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11476071/
Abstract

This study aimed to compare contrast-enhanced ultrasound (CEUS) features of hepatic angiomyolipoma (HAML) and challenging cases of HCC, mainly those with no hepatitis infection but also with a low level of AFP (non-viral AFP- HCC).  The study included pathologically confirmed HAMLs and non-viral AFP- HCCs undergoing CEUS from 2012 to 2023. Sonovue (SV) CEUS and Sonazoid (SZ) CEUS characteristics of the two groups were compared.  The study included 50 HAMLs (24% on SZ-CEUS) and 88 non-viral AFP- HCCs (21.6% on SZ-CEUS). The CEUS characteristics on SZ-CEUS were similar to those on SV-CEUS to a certain extent. HAMLs more frequently displayed no washout and partial washout with partial no washout, so-called PWNW, in the late phase and post-vascular phase, whereas HCCs more commonly exhibited mild washout. In the post-vascular phase, all non-viral AFP- HCCs exhibited washout, thereby facilitating differentiation from no-washoutHAMLs, superior to SV-CEUS, where some non-viral AFP- HCCs still exhibited no washout in late phase that could not be distinguished from HAMLs. It is noteworthy that PWNW was exclusively found in nodules exhibiting hyper- and hypoechoic separation of the nodules, and hyper- and hypoechoic separation of HAMLs in the post-vascular phase on SZ-CEUS demonstrated PWNW more frequently compared to the late phase, which can potentially help distinguish nodules with hyper- and hypoechoic separation as either HAML or non-viral AFP- HCC. Conclusion: This study highlighted the usefulness of SV- and SZ-CEUS for distinguishing HAML and non-viral AFP- HCC and filled in existing gaps regarding the SZ-CEUS features of HAML.

摘要

本研究旨在比较肝血管平滑肌脂肪瘤(HAML)与具有挑战性的肝癌病例(主要是那些无肝炎感染且甲胎蛋白(AFP)水平较低的病例,即非病毒性AFP-HCC)的超声造影(CEUS)特征。该研究纳入了2012年至2023年期间接受CEUS检查且病理确诊的HAML和非病毒性AFP-HCC。比较了两组的声诺维(SV)CEUS和 SonoVue(SZ)CEUS特征。该研究纳入了50例HAML(24%在SZ-CEUS上)和88例非病毒性AFP-HCC(21.6%在SZ-CEUS上)。SZ-CEUS上的CEUS特征在一定程度上与SV-CEUS相似。HAML在晚期和血管后期更常表现为无消退和部分消退伴部分无消退,即所谓的PWNW,而肝癌更常见表现为轻度消退。在血管后期,所有非病毒性AFP-HCC均表现为消退,从而有助于与无消退的HAML相鉴别,优于SV-CEUS,在SV-CEUS中一些非病毒性AFP-HCC在晚期仍表现为无消退,无法与HAML区分。值得注意的是,PWNW仅在表现为结节高回声和低回声分离的结节中发现,并且在SZ-CEUS上,HAML在血管后期的高回声和低回声分离比晚期更频繁地表现出PWNW,这可能有助于区分具有高回声和低回声分离的结节是HAML还是非病毒性AFP-HCC。结论:本研究强调了SV-CEUS和SZ-CEUS在鉴别HAML和非病毒性AFP-HCC方面的有用性,并填补了关于HAML的SZ-CEUS特征的现有空白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/519975e78443/10-1055-a-2318-6654_26029642.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/95167bfcd024/10-1055-a-2318-6654_26029643.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/386aa3364b56/10-1055-a-2318-6654_26029644.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/4221de772ac3/10-1055-a-2318-6654_26029645.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/565b72822e5e/10-1055-a-2318-6654_26029646.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/519975e78443/10-1055-a-2318-6654_26029642.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/95167bfcd024/10-1055-a-2318-6654_26029643.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/386aa3364b56/10-1055-a-2318-6654_26029644.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/4221de772ac3/10-1055-a-2318-6654_26029645.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/565b72822e5e/10-1055-a-2318-6654_26029646.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a479/11476071/519975e78443/10-1055-a-2318-6654_26029642.jpg

相似文献

1
Contrast-enhanced ultrasound features of hepatic angiomyolipoma: comparison with AFP-negative and non-viral hepatocellular carcinoma.肝脏血管平滑肌脂肪瘤的超声造影特征:与甲胎蛋白阴性及非病毒性肝细胞癌的比较
Ultrasound Int Open. 2024 Jun 14;10:a23186654. doi: 10.1055/a-2318-6654. eCollection 2024.
2
Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.评估肝细胞癌的动脉期增强和晚期廓清: SonoVue® 和 Sonazoid® 超声造影的荟萃分析。
Eur Radiol. 2024 Jun;34(6):3795-3812. doi: 10.1007/s00330-023-10371-2. Epub 2023 Nov 22.
3
Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.肝癌肿瘤大小对 SonoVue 超声造影增强特征的影响。
Ultrasound Med Biol. 2024 Jan;50(1):39-46. doi: 10.1016/j.ultrasmedbio.2023.08.022. Epub 2023 Sep 30.
4
Comparison of CT and contrast-enhanced ultrasound findings in hepatic angiomyolipoma with pathological correlations.肝脏血管平滑肌脂肪瘤的CT与对比增强超声表现及病理相关性比较
Abdom Radiol (NY). 2016 Feb;41(2):248-56. doi: 10.1007/s00261-015-0571-0.
5
Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound--A Prospective Study in Non-Cirrhotic Patients.通过基线超声和超声造影联合诊断肝血管平滑肌脂肪瘤——一项针对非肝硬化患者的前瞻性研究
PLoS One. 2015 Jul 6;10(7):e0132290. doi: 10.1371/journal.pone.0132290. eCollection 2015.
6
Clinical and Contrast-enhanced Ultrasound Characteristics of Epithelioid and Classic Hepatic Angiomyolipoma: Comparison With Alpha-fetoprotein-negative Hepatocellular Carcinoma.上皮样和经典型肝血管平滑肌脂肪瘤的临床和对比增强超声特征:与甲胎蛋白阴性肝细胞癌的比较。
Ultrasound Med Biol. 2021 Mar;47(3):446-453. doi: 10.1016/j.ultrasmedbio.2020.11.021. Epub 2021 Jan 7.
7
A Comparative Study of SonoVue and Sonazoid for Contrast-Enhanced Ultrasound CT/MRI Fusion Guidance During Radiofrequency Ablation of Poorly Visualized Hepatic Malignancies: A Prospective Intra-Individual Analysis.超声造影剂声诺维与声振造影剂 SonoVue 用于增强超声 CT/MRI 融合引导射频消融治疗肝内乏血供肿瘤的前瞻性个体内对比研究。
Ultrasound Med Biol. 2024 Dec;50(12):1879-1884. doi: 10.1016/j.ultrasmedbio.2024.08.014. Epub 2024 Sep 20.
8
Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.超声造影剂声诺维与声诺美增强超声在诊断肝细胞癌中的个体内比较。
Abdom Radiol (NY). 2024 May;49(5):1432-1443. doi: 10.1007/s00261-024-04250-7. Epub 2024 Apr 7.
9
Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.使用标准化的超声造影(CEUS)观察肝细胞癌的洗脱现象,包括延长的晚期观察——来自前瞻性多中心 DEGUM 研究的真实世界数据。
Clin Hemorheol Microcirc. 2023;84(4):413-424. doi: 10.3233/CH-231740.
10
Characterization of non-alcoholic fatty liver disease-related hepatocellular carcinoma on contrast-enhanced ultrasound with Sonazoid.使用声诺维对比增强超声对非酒精性脂肪性肝病相关肝细胞癌的特征分析
Ultrasonography. 2025 May;44(3):232-242. doi: 10.14366/usg.24205. Epub 2025 Mar 13.

引用本文的文献

1
Washout on Contrast-Enhanced Ultrasound of Benign Focal Liver Lesions-A Review on Its Frequency and Possible Causes.肝脏良性局灶性病变超声造影剂的洗脱——频率及可能原因综述
Diagnostics (Basel). 2025 Apr 14;15(8):998. doi: 10.3390/diagnostics15080998.

本文引用的文献

1
Diagnostic Performance of Modified Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Patients Without Risk Factors for Hepatocellular Carcinoma: Comparison With World Federation for Ultrasound in Medicine and Biology Guideline.改良型超声造影肝脏成像报告和数据系统在无肝细胞癌危险因素患者中的诊断性能:与世界医学和生物学超声联合会指南的比较
Ultrasound Med Biol. 2024 Feb;50(2):243-250. doi: 10.1016/j.ultrasmedbio.2023.10.008. Epub 2023 Nov 18.
2
Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.肝癌肿瘤大小对 SonoVue 超声造影增强特征的影响。
Ultrasound Med Biol. 2024 Jan;50(1):39-46. doi: 10.1016/j.ultrasmedbio.2023.08.022. Epub 2023 Sep 30.
3
Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.使用标准化的超声造影(CEUS)观察肝细胞癌的洗脱现象,包括延长的晚期观察——来自前瞻性多中心 DEGUM 研究的真实世界数据。
Clin Hemorheol Microcirc. 2023;84(4):413-424. doi: 10.3233/CH-231740.
4
Ultrasound contrast agent Sonazoid for the diagnosis of hepatic epithelioid angiomyolipoma: a case report.超声造影剂声诺维诊断肝脏上皮样血管平滑肌脂肪瘤 1 例报告。
BMC Gastroenterol. 2021 Dec 20;21(1):487. doi: 10.1186/s12876-021-02064-1.
5
Clinical and Contrast-enhanced Ultrasound Characteristics of Epithelioid and Classic Hepatic Angiomyolipoma: Comparison With Alpha-fetoprotein-negative Hepatocellular Carcinoma.上皮样和经典型肝血管平滑肌脂肪瘤的临床和对比增强超声特征:与甲胎蛋白阴性肝细胞癌的比较。
Ultrasound Med Biol. 2021 Mar;47(3):446-453. doi: 10.1016/j.ultrasmedbio.2020.11.021. Epub 2021 Jan 7.
6
Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS.肝脏对比增强超声(CEUS)临床实践指南及良好规范推荐-2020 年 WFUMB 与 EFSUMB、AFSUMB、AIUM 和 FLAUS 合作更新版。
Ultrasound Med Biol. 2020 Oct;46(10):2579-2604. doi: 10.1016/j.ultrasmedbio.2020.04.030. Epub 2020 Jul 24.
7
Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid.肝脏超声造影成像: SonoVue 和 Sonazoid 的临床证据综述。
Abdom Radiol (NY). 2020 Nov;45(11):3779-3788. doi: 10.1007/s00261-020-02573-9.
8
Comparison of hepatic epithelioid angiomyolipoma and non-hepatitis B, non-hepatitis C hepatocellular carcinoma on contrast-enhanced ultrasound.肝脏上皮样血管平滑肌脂肪瘤与非乙肝、非丙肝肝细胞癌的超声造影对比
Diagn Interv Imaging. 2020 Nov;101(11):733-738. doi: 10.1016/j.diii.2020.03.005. Epub 2020 Apr 21.
9
Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma.肝上皮样血管平滑肌脂肪瘤与肝细胞癌的超声造影表现及鉴别诊断。
Ultrasound Med Biol. 2020 Jun;46(6):1403-1411. doi: 10.1016/j.ultrasmedbio.2020.02.001. Epub 2020 Mar 10.
10
Imaging hepatic angiomyolipomas: key features and avoiding errors.肝脏血管平滑肌脂肪瘤的影像学表现:关键特征与误诊防范。
Clin Radiol. 2020 Feb;75(2):88-99. doi: 10.1016/j.crad.2019.09.135. Epub 2019 Oct 31.